A review of the pharmacology and clinical activity of new chemotherapeutic agents in lung cancer
- 1 February 1998
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 24 (1) , 35-53
- https://doi.org/10.1016/s0305-7372(98)90070-6
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Radiosensitizing NucleosidesJNCI Journal of the National Cancer Institute, 1996
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Activity of docetaxel (Taxotere) in small cell lung cancerEuropean Journal Of Cancer, 1994
- Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive daysEuropean Journal Of Cancer, 1994
- Taxotere toxicity — Protective effects of premedicationEuropean Journal Of Cancer, 1993
- Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patientsEuropean Journal Of Cancer, 1993
- Effects of taxotere on murine and human tumor cell linesBiochemical and Biophysical Research Communications, 1992
- Phase I–II study of vinorelbine (Navelbine®) plus cisplatin in advanced non-small cell lung cancerEuropean Journal Of Cancer, 1992
- CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties.Journal of Pharmacobio-Dynamics, 1991
- Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly.The Journal of cell biology, 1983